Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of the sweat-reducing effect of botulinum toxins by concentration
2009-013684-19Phase 4Active
- Sponsor
- Region Uppsala
- Start
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A and botulinum toxin type b in hyperhidrosis (4 arms), sponsored by Region Uppsala. Primary endpoints: Primary efficacy endpoint and Duration of effect. Started Jul 2009; status: active.
02
Drugs
botulinum toxin type Abotulinum toxin type b
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on 2009-013684-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013684-19.